563 related articles for article (PubMed ID: 33861750)
1. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF
PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750
[TBL] [Abstract][Full Text] [Related]
2. Risk factors of severe cases with COVID-19: a meta-analysis.
Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
[TBL] [Abstract][Full Text] [Related]
3. Study on Laboratory Indicators Related to Lung Injury of Corona Virus Disease 2019.
Zhang Y; Chen Q; Yao L; Chen J; Yu X
Clin Lab; 2021 Jan; 67(1):. PubMed ID: 33491433
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
5. Cytokine storm in severe COVID-19 pneumonia.
Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19).
Lohse A; Klopfenstein T; Balblanc JC; Royer PY; Bossert M; Gendrin V; Charpentier A; Bozgan AM; Badie J; Bourgoin C; Contreras R; Mazurier I; Conrozier T; Zayet S
Microbes Infect; 2020 Oct; 22(9):500-503. PubMed ID: 32574789
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of acute respiratory distress syndrome in adults hospitalised for severe SARS-CoV-2 infection in Tenerife Island, Spain.
Figueira Gonçalves JM; Hernández Pérez JM; Acosta Sorensen M; Wangüemert Pérez AL; Martín Ruiz de la Rosa E; Trujillo Castilla JL; Díaz Pérez D; Ramallo-Fariña Y
BMC Res Notes; 2020 Dec; 13(1):555. PubMed ID: 33298124
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
Li J; He X; Yuan Yuan ; Zhang W; Li X; Zhang Y; Li S; Guan C; Gao Z; Dong G
Am J Infect Control; 2021 Jan; 49(1):82-89. PubMed ID: 32540370
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus.
Jing Liang J; Liu J; Chen Y; Ye B; Li N; Wang X; Tang M; Shao J
Diabetes Res Clin Pract; 2020 Sep; 167():108351. PubMed ID: 32711001
[TBL] [Abstract][Full Text] [Related]
10. Routine laboratory testing to determine if a patient has COVID-19.
Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
[TBL] [Abstract][Full Text] [Related]
11. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
[TBL] [Abstract][Full Text] [Related]
12. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
Zhao Y; Yin L; Patel J; Tang L; Huang Y
J Med Virol; 2021 Jul; 93(7):4358-4369. PubMed ID: 33739452
[TBL] [Abstract][Full Text] [Related]
13. Laboratory biomarkers associated with COVID-19 severity and management.
Keddie S; Ziff O; Chou MKL; Taylor RL; Heslegrave A; Garr E; Lakdawala N; Church A; Ludwig D; Manson J; Scully M; Nastouli E; Chapman MD; Hart M; Lunn MP
Clin Immunol; 2020 Dec; 221():108614. PubMed ID: 33153974
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study.
Kocayiğit H; Özmen Süner K; Tomak Y; Demir G; Kocayiğit İ; Yaylacı S; Aydemir Y; Köroğlu M; Karabay O; Öztürk MH; Erdem AF
Turk J Med Sci; 2021 Apr; 51(2):440-447. PubMed ID: 33185365
[TBL] [Abstract][Full Text] [Related]
15. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
[TBL] [Abstract][Full Text] [Related]
16. The Clinical Characteristics and Risk Factors of Severe COVID-19.
Hu J; Wang Y
Gerontology; 2021; 67(3):255-266. PubMed ID: 33406518
[TBL] [Abstract][Full Text] [Related]
17. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
[No Abstract] [Full Text] [Related]
18. Baseline laboratory parameters for preliminary diagnosis of COVID-19 among children: a cross-sectional study.
Dobrijević D; Katanić J; Todorović M; Vučković B
Sao Paulo Med J; 2022; 140(5):691-696. PubMed ID: 35976368
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of clinical and laboratory parameters associated with increased severity among COVID-19 patients.
Mehta AA; Haridas N; Belgundi P; Jose WM
Diabetes Metab Syndr; 2021; 15(2):535-541. PubMed ID: 33711574
[TBL] [Abstract][Full Text] [Related]
20. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
Wang Z; Wang Z
BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
